10X Genomics challenged claims in Bio-Rad’s U.S. Pat. No. 9,562,837 and 9,896,722. The PTAB issued four mixed Final Written Decisions in 10X Genomics Inc. v. Bio-Rad Labs., Inc., IPR2020-00086, -00087, -00088, and -00089, finding most claims unpatentable but allowing a few to survive.
Monday, April 12, 2021
The U.S. International Trade Commission (“ITC”) recently terminated
CERTAIN MOTORIZED SELF-BALANCING VEHICLES, Investigation No. 337-TA-1000, brought by Razor USA LLC against alleged infringers of a patent related to electric hoverboards, denying Razor any relief. In doing so, the ITC confirmed that an original patent is surrendered when a Reissue Patent issues, even if a pending Continuation Application from the Reissue Application includes the claims of the original patent.
The ITC instituted Investigation No. 337-TA-1000 in May 2016. On the same day the ITC instituted the investigation, the Complainant, Razor USA LLC, sought reissue of the asserted patent, U.S. Patent No. 8,738,278 (“the ’278 patent”), but subsequently requested that the PTO suspend examination of the reissue application during the investigation, which it did. The Investigation proceeded to a hearing and the ITC found no violation of section 337. The ITC found that n